Current Enterprise Value (EV)
Current share price (P) | $426.29 |
No. shares of common stock outstanding | 258,307,816 |
US$ in thousands | |
Common equity (market value)1 | 110,114,039) |
Add: Preferred stock, $0.01 par value; none issued and outstanding (per books) | —) |
Total equity | 110,114,039) |
Add: Current finance lease liabilities (per books) | 50,600) |
Add: Long-term finance lease liabilities (per books) | 376,100) |
Total equity and debt | 110,540,739) |
Less: Cash and cash equivalents | 10,369,100) |
Less: Marketable securities | 849,200) |
Enterprise value (EV) | 99,322,439) |
Based on: 10-K (reporting date: 2023-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 426.29 × 258,307,816
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Vertex Pharmaceuticals Inc. Annual Report.
3 2023 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 426.29 × 258,307,816
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Vertex Pharmaceuticals Inc. EV increased from 2021 to 2022 and from 2022 to 2023. |